NCT05772182

Brief Summary

Noninvasive evaluation of the electrical status of the heart is based on the standard ECG but remains suboptimal due to difficulties with arrhythmia characterization and location. Electrocardiographic Imaging (ECGI) provides maps of cardiac electrical excitation in relation to the anatomy of the heart using an extensive number of electrodes from the body surface. The applicant will develop a systematic evaluation of the ECGI as a tool to detect cardiac regions of interest in cardiac arrhythmias.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
362

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Dec 2022

Typical duration for all trials

Geographic Reach
1 country

3 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2022

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

March 6, 2023

Completed
10 days until next milestone

First Posted

Study publicly available on registry

March 16, 2023

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 13, 2025

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

January 13, 2026

Completed
Last Updated

February 17, 2026

Status Verified

February 1, 2026

Enrollment Period

2.1 years

First QC Date

March 6, 2023

Last Update Submit

February 16, 2026

Conditions

Keywords

Non-invasiveElectrocardiographic imaging (ECGI)

Outcome Measures

Primary Outcomes (1)

  • Accuracy of ECGI for detecting cardiac region of interest

    Accuracy of the ECGI non-invasive cardiac mapping system for detecting cardiac regions of interest in cardiac arrhythmias through direct confrontation with invasive endocardial contact measures.

    1 year

Secondary Outcomes (3)

  • Correlation of ECGI with an expert's interpretation of the standard ECG

    1 year

  • ECGI's ability to accurately predict the success of ablation procedures and recurrence

    1 year

  • Cost-effectiveness rate of the ECGI

    1 year

Study Arms (1)

Groups/Cohorts

Patients undergoing intervention for arrhythmia (electrophysiologic study and/or intracardiac device implantation) with clinical indication

Device: ACORYS MAPPING SYSTEM

Interventions

Diagnostic Test: ECG-Imaging Diagnostic Test: Standard 12-lead ECG Diagnostic Test: Endocardial mapping and/or pacing

Groups/Cohorts

Eligibility Criteria

Age18 Years+
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The patient's population will include those with an indication for an invasive electroanatomic study and/or intracardiac device implantation.

You may qualify if:

  • Indication for an invasive electroanatomic study and/or intracardiac device implantation.
  • Having obtained and signed the informed consent for study participation.
  • Ability to stand, to be able to obtain the 3D torso reconstruction necessary for the ECGI system.

You may not qualify if:

  • \<18 years old
  • Inability to perform an endocardial catheterization and/or device implantation.
  • Physical or mental disability to understand and accept the informed consent.
  • Inability to stand to obtain the 3D torso reconstruction.
  • active coronary ischemia or decompensated heart failure
  • Intracardiac clot on trans-esophageal echocardiography
  • Pregnancy.
  • Disorganized arrhythmias (i.e. atrial fibrillation, polymorphic ventricular tachycardia).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Hospital Clínic de Barcelona

Barcelona, Barcelona, 08036, Spain

Location

Hospital General Universitario Gregorio Marañón

Madrid, Madrid, 28007, Spain

Location

Hospital Universitari i Politècnic La Fe

Valencia, Valencia, 46026, Spain

Location

MeSH Terms

Conditions

Arrhythmias, Cardiac

Condition Hierarchy (Ancestors)

Heart DiseasesCardiovascular DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
1 Day
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 6, 2023

First Posted

March 16, 2023

Study Start

December 1, 2022

Primary Completion

January 13, 2025

Study Completion

January 13, 2026

Last Updated

February 17, 2026

Record last verified: 2026-02

Data Sharing

IPD Sharing
Will not share

Locations